Involvement of D1/D2 dopamine antagonists upon open-arms exploratory behaviours induced by intra-nucleus accumbens shell administration of N-methyl-D-aspartate

Folia Neuropathologica

Volumn 52, Issue 2, 2014, Pages 164-178

  Razavi, Samira ^a   Haeri Rohani, Ali ^a   Eidi, Akram ^a   Zarrindast, Mohammad R ^b,c,d,e  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b INSTITUTE FOR COGNITIVE SCIENCE STUDIES ICSS   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e INSTITUTE FOR RESEARCH IN FUNDAMENTAL SCIENCES IPM   (Iran)

Author keywords

Anxiety; Aversive learning; Dopamine; Elevated plus maze; Glutamate; Nucleus accumbens; Rat

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; SULPIRIDE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; N METHYLASPARTIC ACID;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; AVERSIVE BEHAVIOR; AVOIDANCE BEHAVIOR; CANNULA; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ELEVATED PLUS MAZE TEST; EXPLORATORY BEHAVIOR; IMPLANTATION; LEARNING; LOCOMOTION; MALE; MEMORY; MEMORY DISORDER; MICROINJECTION; NONHUMAN; NUCLEUS ACCUMBENS; RAT; REPEAT PROCEDURE; ANIMAL; DRUG EFFECTS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MAZE TEST; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ANIMALS; DOPAMINE D2 RECEPTOR ANTAGONISTS; EXPLORATORY BEHAVIOR; INJECTIONS, INTRAVENTRICULAR; MALE; MAZE LEARNING; MICROINJECTIONS; N-METHYLASPARTATE; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2;

EID: 84903560489     PISSN: 16414640     EISSN: 1509572X     Source Type: Journal    
DOI: 10.5114/fn.2014.43788     Document Type: Article

References (98)

1. Adriani W, Felici A, Sargolini F, Roullet P, Usiello A, Oliverio A, Mele A. N-methyl-D-aspartate and dopamine receptor involvement in the modulation of locomotor activity and memory processes. Exp Brain Res 1998; 123: 52-59.
2. Adriani W, Sargolini F, Coccurello R, Oliverio A, Mele A. Role of dopaminergic system in reactivity to spatial and non-spatial changes in mice. Psychopharmacology (Berl) 2000; 150: 67-76.
3. Ahmadi H, Nasehi M, Rostami P, Zarrindast MR. Involvement of the nucleus accumbens shell dopaminergic system in prelimbic NMDA-induced anxiolytic-like behaviors. Neuropharmacology 2013; 71: 112-123.
4. Ahn SM, Kim SW, Choe ES. Cocaine increases immunoglobulin heavy chain binding protein and caspase-12 expression in the rat dorsal striatum. Psychopharmacology (Berl) 2007; 195: 407-414.
5. Arnsten AF. Catecholamine modulation of prefrontal cortical cognitive function. Trends Cogn Sci 1998; 2: 436-447.
6. Asth L, Lobao-Soares B, Andre E, Soares Vde P, Gavioli EC. The elevated T-maze task as an animal model to simultaneously investigate the effects of drugs on long-term memory and anxiety in mice. Brain Res Bull 2012; 87: 526-533.
7. Baiardi G, Ruiz AM, Beling A, Borgonovo J, Martinez G, Landa AI, Sosa MA, Gargiulo PA. Glutamatergic ionotropic blockade within accumbens disrupts working memory and might alter the endocytic machinery in rat accumbens and prefrontal cortex. J Neural Transm 2007; 114: 1519-1528.
8. Bardo MT, Hammer RP, Jr. Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: resistance to differential rearing conditions. Neuroscience 1991; 45: 281-290.
9. Barkus C, McHugh SB, Sprengel R, Seeburg PH, Rawlins JN, Bannerman DM. Hippocampal NMDA receptors and anxiety: at the interface between cognition and emotion. Eur J Pharmacol 2010; 626: 49-56.
10. Bertoglio LJ, Carobrez AP. Previous maze experience required to increase open arms avoidance in rats submitted to the elevated plus-maze model of anxiety. Behav Brain Res 2000; 108: 197-203.
11. Bossert JM, Poles GC, Wihbey KA, Koya E, Shaham Y. Differential effects of blockade of dopamine D1-family receptors in nucleus accumbens core or shell on reinstatement of heroin seeking induced by contextual and discrete cues. J Neurosci 2007; 27: 12655-12663.
12. Cardinal RN, Everitt BJ. Neural and psychological mechanisms underlying appetitive learning: links to drug addiction. Curr Opin Neurobiol 2004; 14: 156-162.
13. Carvalho MC, Albrechet-Souza L, Masson S, Brandao ML. Changes in the biogenic amine content of the prefrontal cortex, amygdala, dorsal hippocampus, and nucleus accumbens of rats submitted to single and repeated sessions of the elevated plus-maze test. Braz J Med Biol Res 2005; 38: 1857-1866.
14. Cheer JF, Wassum KM, Sombers LA, Heien ML, Ariansen JL, Aragona BJ, Phillips PE, Wightman RM. Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. J Neurosci 2007; 27: 791-795.
15. Coccurello R, Adriani W, Oliverio A, Mele A. Effect of intra-accumbens dopamine receptor agents on reactivity to spatial and non-spatial changes in mice. Psychopharmacology (Berl) 2000; 152: 189-199.
16. Da Cunha IC, Jose RF, Orlandi Pereira L, Pimenta JA, Oliveira de Souza IA, Reiser R, Moreno H, Jr., Marino Neto J, Paschoalini MA, Faria MS. The role of nitric oxide in the emotional learning of rats in the plus-maze. Physiol Behav 2005; 84: 351-358.
17. da Cunha IC, Lopes AP, Steffens SM, Ferraz A, Vargas JC, de Lima TC, Marino Neto J, Paschoalini MA, Faria MS. The microinjection of AMPA receptor antagonist into the accumbens shell, but not into the accumbens core, induces anxiolysis in an animal model of anxiety. Behav Brain Res 2008; 188: 91-99.
18. Dalia A, Uretsky NJ, Wallace LJ. Dopaminergic agonists administered into the nucleus accumbens: effects on extracellular glutamate and on locomotor activity. Brain Res 1998; 788: 111-117.
19. Dawson VL, Dawson TM. Deadly conversations: nuclear-mitochondrial cross-talk. J Bioenerg Biomembr 2004; 36: 287-294.
20. Deutch AY, Cameron DS. Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell. Neuroscience 1992; 46: 49-56.
21. Dunn RW, Corbett R, Fielding S. Effects of 5-HT1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze. Eur J Pharmacol 1989; 169: 1-10.
22. Fernandes C, File SE. The influence of open arm ledges and maze experience in the elevated plus-maze. Pharmacol Biochem Behav 1996; 54: 31-40.
23. Floresco SB, Todd CL, Grace AA. Glutamatergic afferents from the hippocampus to the nucleus accumbens regulate activity of ventral tegmental area dopamine neurons. J Neurosci 2001; 21: 4915-4922.
24. Gal G, Joel D, Gusak O, Feldon J, Weiner I. The effects of electrolytic lesion to the shell subterritory of the nucleus accumbens on delayed non-matching-to-sample and four-arm baited eight-arm radial-maze tasks. Behav Neurosci 1997; 111: 92-103.
25. Garpenstrand H, Annas P, Ekblom J, Oreland L, Fredrikson M. Human fear conditioning is related to dopaminergic and serotonergic biological markers. Behav Neurosci 2001; 115: 358-364.
26. Guimaraes FS, Carobrez AP, De Aguiar JC, Graeff FG. Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal grey. Psychopharmacology (Berl) 1991; 103: 91-94.
27. Hara Y, Pickel VM. Overlapping intracellular and differential synaptic distributions of dopamine D1 and glutamate N-methyl-D-aspartate receptors in rat nucleus accumbens. J Comp Neurol 2005; 492: 442-455.
28. Horger BA, Roth RH. The role of mesoprefrontal dopamine neurons in stress. Crit Rev Neurobiol 1996; 10: 395-418.
29. Huang YH, Ishikawa M, Lee BR, Nakanishi N, Schluter OM, Dong Y. Searching for presynaptic NMDA receptors in the nucleus accumbens. J Neurosci 2011; 31: 18453-18463.
30. Ikeda H, Kamei J, Koshikawa N, Cools AR. Nucleus accumbens and dopamine-mediated turning behavior of the rat: role of accumbal non-dopaminergic receptors. J Pharmacol Sci 2012; 120: 152-164.
31. Imperato A, Honore T, Jensen LH. Dopamine release in the nucleus caudatus and in the nucleus accumbens is under glutamatergic control through non-NMDA receptors: a study in freely-moving rats. Brain Res 1990; 530: 223-228.
32. Jacewicz M, Czapski GA, Katkowska I, Strosznajder RP. Systemic administration of lipopolysaccharide impairs glutathione redox state and object recognition in male mice. The effect of PARP-1 inhibitor. Folia Neuropathol 2009; 47: 321-328.
33. Jamali-Raeufy N, Nasehi M, Zarrindast MR. Influence of N-methyl D-aspartate receptor mechanism on WIN55,212-2-induced amnesia in rat dorsal hippocampus. Behav Pharmacol 2011; 22: 645-654.
34. Jay TM. Dopamine: a potential substrate for synaptic plasticity and memory mechanisms. Prog Neurobiol 2003; 69: 375-390.
35. Jongen-Relo AL, Kaufmann S, Feldon J. A differential involvement of the shell and core subterritories of the nucleus accumbens of rats in memory processes. Behav Neurosci 2003; 117: 150-168.
36. Kalivas PW, Duffy P. Dopamine regulation of extracellular glutamate in the nucleus accumbens. Brain Res 1997; 761: 173-177.
37. Kalivas PW, Duffy P, Barrow J. Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes. J Pharmacol Exp Ther 1989; 251: 378-387.
38. Kew JN, Kemp JA. Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology (Berl) 2005; 179: 4-29.
39. Kienast T, Heinz A. Dopamine and the diseased brain. CNS Neurol Disord Drug Targets 2006; 5: 109-131.
40. Kitamura M, Koshikawa N, Yoneshige N, Cools AR. Behavioural and neurochemical effects of cholinergic and dopaminergic agonists administered into the accumbal core and shell in rats. Neuropharmacology 1999; 38: 1397-1407.
41. Klein S, Hadamitzky M, Koch M, Schwabe K. Role of glutamate receptors in nucleus accumbens core and shell in spatial behaviour of rats. Neuroscience 2004; 128: 229-238.
42. Koshikawa N, Kitamura M, Kobayashi M, Cools AR. Contralateral turning elicited by unilateral stimulation of dopamine D2 and D1 receptors in the nucleus accumbens of rats is due to stimulation of these receptors in the shell, but not the core, of this nucleus. Psychopharmacology (Berl) 1996; 126: 185-190.
43. Kuo YM, Liang KC, Chen HH, Cherng CG, Lee HT, Lin Y, Huang AM, Liao RM, Yu L. Cocaine-but not methamphetamine-associated memory requires de novo protein synthesis. Neurobiol Learn Mem 2007; 87: 93-100.
44. Lee C, Rodgers RJ. Antinociceptive effects of elevated plus-maze exposure: influence of opiate receptor manipulations. Psychopharmacology (Berl) 1990; 102: 507-513.
45. Lee DK, Koh WC, Shim YB, Shim I, Choe ES. Repeated cocaine administration increases nitric oxide efflux in the rat dorsal striatum. Psychopharmacology (Berl) 2010; 208: 245-256.
46. Liu JL, Li M, Dang XR, Wang ZH, Rao ZR, Wu SX, Li YQ, Wang W. A NMDA receptor antagonist, MK-801 impairs consolidating extinction of auditory conditioned fear responses in a Pavlovian model. PLoS One 2009; 4: e7548.
47. Maldonado-Irizarry CS, Kelley AE. Excitatory amino acid receptors within nucleus accumbens subregions differentially mediate spatial learning in the rat. Behav Pharmacol 1995; 6: 527-539.
48. Martinez G, Ropero C, Funes A, Flores E, Blotta C, Landa AI, Gargiulo PA. Effects of selective NMDA and non-NMDA blockade in the nucleus accumbens on the plus-maze test. Physiol Behav 2002; 76: 219-224.
49. Martinez G, Ropero C, Funes A, Flores E, Landa AI, Gargiulo PA. AP-7 into the nucleus accumbens disrupts acquisition but does not affect consolidation in a passive avoidance task. Physiol Behav 2002; 76: 205-212.
50. Martinez RC, Oliveira AR, Macedo CE, Molina VA, Brandao ML. Involvement of dopaminergic mechanisms in the nucleus accumbens core and shell subregions in the expression of fear conditioning. Neurosci Lett 2008; 446: 112-116.
51. McGaugh JL. The amygdala modulates the consolidation of memories of emotionally arousing experiences. Annu Rev Neurosci 2004; 27: 1-28.
52. Mele A, Avena M, Roullet P, De Leonibus E, Mandillo S, Sargoli-ni F, Coccurello R, Oliverio A. Nucleus accumbens dopamine receptors in the consolidation of spatial memory. Behav Pharmacol 2004; 15: 423-431.
53. Morari M, Marti M, Sbrenna S, Fuxe K, Bianchi C, Beani L. Reciprocal dopamine-glutamate modulation of release in the basal ganglia. Neurochem Int 1998; 33: 383-397.
54. Mudo G, Persson H, Timmusk T, Funakoshi H, Bindoni M, Belluardo N. Increased expression of trkB and trkC messenger RNAs in the rat forebrain after focal mechanical injury. Neuroscience 1993; 57: 901-912.
55. Nasehi M, Mafi F, Oryan S, Nasri S, Zarrindast MR. The effects of dopaminergic drugs in the dorsal hippocampus of mice in the nicotine-induced anxiogenic-like response. Pharmacol Biochem Behav 2011; 98: 468-473.
56. Nasehi M, Piri M, Nouri M, Farzin D, Nayer-Nouri T, Zarrindast MR. Involvement of dopamine D1/D2 receptors on harmane-induced amnesia in the step-down passive avoidance test. Eur J Pharmacol 2010; 634: 77-83.
57. Ozawa S, Kamiya H, Tsuzuki K. Glutamate receptors in the mammalian central nervous system. Prog Neurobiol 1998; 54: 581-618.
58. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 6rd ed. Academic Press, London 2007.
59. Pellow S, Chopin P, File SE, Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985; 14: 149-167.
60. Pezze MA, Feldon J. Mesolimbic dopaminergic pathways in fear conditioning. Prog Neurobiol 2004; 74: 301-320.
61. Plaznik A, Palejko W, Nazar M, Jessa M. Effects of antagonists at the NMDA receptor complex in two models of anxiety. Eur Neuropsychopharmacol 1994; 4: 503-512.
62. Rezayof A, Motevasseli T, Rassouli Y, Zarrindast MR. Dorsal hippocampal dopamine receptors are involved in mediating ethanol state-dependent memory. Life Sci 2007; 80: 285-292.
63. Riaza Bermudo-Soriano C, Perez-Rodriguez MM, Vaquero-Lorenzo C, Baca-Garcia E. New perspectives in glutamate and anxiety. Pharmacol Biochem Behav 2012; 100: 752-774.
64. Sargolini F, Florian C, Oliverio A, Mele A, Roullet P. Differential involvement of NMDA and AMPA receptors within the nucleus accumbens in consolidation of information necessary for place navigation and guidance strategy of mice. Learn Mem 2003; 10: 285-292.
65. Schacter GB, Yang CR, Innis NK, Mogenson GJ. The role of the hippocampal-nucleus accumbens pathway in radial-arm maze performance. Brain Res 1989; 494: 339-349.
66. Sesack SR, Pickel VM. In the rat medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other. Brain Res 1990; 527: 266-279.
67. Sesack SR, Pickel VM. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J Comp Neurol 1992; 320: 145-160.
68. Setlow B, McGaugh JL. Sulpiride infused into the nucleus accumbens posttraining impairs memory of spatial water maze training. Behav Neurosci 1998; 112: 603-610.
69. Shin EH, Bian S, Shim YB, Rahman MA, Chung KT, Kim JY, Wang JQ, Choe ES. Cocaine increases endoplasmic reticulum stress protein expression in striatal neurons. Neuroscience 2007; 145: 621-630.
70. Smith-Roe SL, Kelley AE. Coincident activation of NMDA and dopamine D1 receptors within the nucleus accumbens core is required for appetitive instrumental learning. J Neurosci 2000; 20: 7737-7742.
71. Smith-Roe SL, Sadeghian K, Kelley AE. Spatial learning and performance in the radial arm maze is impaired after N-methyl-D-aspartate (NMDA) receptor blockade in striatal subregions. Behav Neurosci 1999; 113: 703-717.
72. Smith JA, Mo Q, Guo H, Kunko PM, Robinson SE. Cocaine increases extraneuronal levels of aspartate and glutamate in the nucleus accumbens. Brain Res 1995; 683: 264-269.
73. Solati J. Dorsal hippocampal N-methyl-D-aspartate glutamatergic and delta-opioidergic systems modulate anxiety behaviors in rats in a noninteractive manner. Kaohsiung J Med Sci 2011; 27: 485-493.
74. Stern CA, Do Monte FH, Gazarini L, Carobrez AP, Bertoglio LJ. Activity in prelimbic cortex is required for adjusting the anxiety response level during the elevated plus-maze retest. Neuroscience 2010; 170: 214-222.
75. Strosznajder JB, Jesko H, Strosznajder RP. Age-related alteration of poly(ADP-ribose) polymerase activity in different parts of the brain. Acta Biochim Pol 2000; 47: 331-337.
76. Strosznajder RP, Jesko H, Adamczyk A. Effect of aging and oxidative/ genotoxic stress on poly(ADP-ribose) polymerase-1 activity in rat brain. Acta Biochim Pol 2005; 52: 909-914.
77. Strosznajder RP, Jesko H, Zambrzycka A. Poly(ADP-ribose) polymerase: the nuclear target in signal transduction and its role in brain ischemia-reperfusion injury. Mol Neurobiol 2005; 31: 149-167.
78. Tonetto LL, Terzian AL, Del Bel EA, Guimaraes FS, Resstel LB. Inhibition of the NMDA receptor/Nitric Oxide pathway in the dorsolateral periaqueductal gray causes anxiolytic-like effects in rats submitted to the Vogel conflict test. Behav Brain Funct 2009; 5:5
79. Treit D, Menard J, Royan C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav 1993; 44: 463-469.
80. Voorn P, Jorritsma-Byham B, Van Dijk C, Buijs RM. The dopaminergic innervation of the ventral striatum in the rat: a light-and electron- microscopical study with antibodies against dopamine. J Comp Neurol 1986; 251: 84-99.
81. Walaas I. Biochemical evidence for overlapping neocortical and allocortical glutamate projections to the nucleus accumbens and rostral caudatoputamen in the rat brain. Neuroscience 1981; 6: 399-405.
82. Wang W, Dever D, Lowe J, Storey GP, Bhansali A, Eck EK, Nitulescu I, Weimer J, Bamford NS. Regulation of prefrontal excitatory neurotransmission by dopamine in the nucleus accumbens core. J Physiol 2012; 590: 3743-3769.
83. Wang Y, Dawson VL, Dawson TM. Poly(ADP-ribose) signals to mitochondrial AIF: a key event in parthanatos. Exp Neurol 2009; 218: 193-202.
84. Wong AC, Shetreat ME, Clarke JO, Rayport S. D1-and D2-like dopamine receptors are co-localized on the presynaptic varicosities of striatal and nucleus accumbens neurons in vitro. Neuroscience 1999; 89: 221-233.
85. Yang JH, Choe ES. Repeated cocaine administration increases cleaved poly(ADP-ribose) polymerase-1 expression in the rat dorsal striatum. Neurosci Lett 2010; 471: 58-61.
86. Yu SW, Wang H, Dawson TM, Dawson VL. Poly(ADP-ribose) polymerase-1 and apoptosis inducing factor in neurotoxicity. Neurobiol Dis 2003; 14: 303-317.
87. Zahm DS, Heimer L. Specificity in the efferent projections of the nucleus accumbens in the rat: comparison of the rostral pole projection patterns with those of the core and shell. J Comp Neurol 1993; 327: 220-232.
88. Zahrt J, Taylor JR, Mathew RG, Arnsten AF. Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci 1997; 17: 8528-8535.
89. Zajaczkowski W, Frankiewicz T, Parsons CG, Danysz W. Uncompetitive NMDA receptor antagonists attenuate NMDA-induced impairment of passive avoidance learning and LTP. Neuropharmacology 1997; 36: 961-971.
90. Zarrindast MR, Khalifeh S, Rezayof A, Rostami P, Aghamohammadi Sereshki A, Zahmatkesh M. Involvement of rat dopaminergic system of nucleus accumbens in nicotine-induced anxiogenic-like behaviors. Brain Res 2012; 1460: 25-32.
91. Zarrindast MR, Naghdi-Sedeh N, Nasehi M, Sahraei H, Bahrami F, Asadi F. The effects of dopaminergic drugs in the ventral hippocampus of rats in the nicotine-induced anxiogenic-like response. Neurosci Lett 2010; 475: 156-160.
92. Zarrindast MR, Nasehi M, Khansari M, Bananej M. Influence of nitric oxide agents in the rat amygdala on anxiogenic-like effect induced by histamine. Neurosci Lett 2010; 489: 38-42.
93. Zarrindast MR, Nasehi M, Khansari M, Bananej M. Influence of nitric oxide agents in the rat amygdala on anxiogenic-like effect induced by histamine. Neurosci Lett 2011; 489: 38-42.
94. Zarrindast MR, Nasehi M, Pournaghshband M, Ghorbani Yekta B. Dopaminergic system in CA1 modulates MK-801 induced anxiolytic-like responses. Pharmacol Biochem Behav 2012; 103: 102-110.
95. Zarrindast MR, Solati J, Oryan S, Parivar K. Effect of intra-amygdala injection of nicotine and GABA receptor agents on anxiety-like behaviour in rats. Pharmacology 2008; 82: 276-284.
96. Zarrindast MR, Sroushi A, Bananej M, Vousooghi N, Hamidkhaniha S. Involvement of the dopaminergic receptors of the rat basolateral amygdala in anxiolytic-like effects of the cholinergic system. Eur J Pharmacol 2011; 672: 106-112.
97. Zarrindast MR, Torabi M, Rostami P, Fazli-Tabaei S. The effects of histaminergic agents in the dorsal hippocampus of rats in the elevated plus-maze test of anxiety. Pharmacol Biochem Behav 2006; 85: 500-506.
98. Zarrindast MR, Valizadegan F, Rostami P, Rezayof A. Histaminergic system of the lateral septum in the modulation of anxiety-like behaviour in rats. Eur J Pharmacol 2008; 583: 108-114.